- Conditions
- Status Asthmaticus, Asthma
- Interventions
- Montelukast, sterile water
- Drug · Other
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NIH
- Eligibility
- 6 Years to 18 Years
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2010
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–8
of 8
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Bronchopulmonary Dysplasia (BPD), Premature Births, Critical Illness
- Interventions
- montelukast 4 mg granule, Placebo
- Drug
- Lead sponsor
- Duke University
- Other
- Eligibility
- 7 Days to 28 Days
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 5
- States / cities
- Little Rock, Arkansas • Amherst, Massachusetts • Las Vegas, Nevada + 2 more
- Conditions
- Fabry's Disease
- Interventions
- AGALSIDASE BETA (GZ419828), Acetaminophen, Diphenhydramine, Dexamethasone, Montelukast, Loratadine, Cetirizine, Fexofenadine
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 2 Years to 65 Years
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 5
- States / cities
- Santa Monica, California • Atlanta, Georgia • Grand Rapids, Michigan + 2 more
- Conditions
- Asthma; Status, Asthma in Children, Asthma Acute, Asthma Attack, Acute Asthma Exacerbation
- Interventions
- Montelukast Oral Granules
- Drug
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Eligibility
- 5 Years to 17 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee
- Conditions
- Atopic Dermatitis
- Interventions
- Montelukast, Placebo
- Drug
- Lead sponsor
- 1st Allergy & Clinical Research Center
- Other
- Eligibility
- 1 Year to 8 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 2
- States / cities
- Centennial, Colorado • Thornton, Colorado
- Conditions
- Status Asthmaticus, Asthma
- Interventions
- Montelukast, Sterile water
- Drug · Other
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NIH
- Eligibility
- 2 Years to 5 Years
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2010
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Status Asthmaticus
- Interventions
- Montelukast Oral Granules, Albuterol, Corticosteroid
- Drug
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Eligibility
- 4 Years to 12 Years
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee
- Conditions
- Asthma, Wheezing
- Interventions
- daily fluticasone propionate, Montelukast, as-needed fluticasone propionate
- Drug
- Lead sponsor
- Milton S. Hershey Medical Center
- Other
- Eligibility
- 12 Months to 59 Months
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 13
- States / cities
- Tucson, Arizona • Oakland, California • San Francisco, California + 9 more